Cargando…
Vitiligo - Part 1()
Vitiligo is a chronic stigmatizing disease, already known for millennia, which mainly affects melanocytes from epidermis basal layer, leading to the development of hypochromic and achromic patches. Its estimated prevalence is 0.5% worldwide. The involvement of genetic factors controlling susceptibil...
Autores principales: | Tarlé, Roberto Gomes, do Nascimento, Liliane Machado, Mira, Marcelo Távora, de Castro, Caio Cesar Silva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056705/ https://www.ncbi.nlm.nih.gov/pubmed/24937821 http://dx.doi.org/10.1590/abd1806-4841.20142573 |
Ejemplares similares
-
Vitiligo - Part 2 - classification, histopathology and treatment*
por: Reichert Faria, Adriane, et al.
Publicado: (2014) -
Experimental approaches to assess melanocytes mosaicism in segmental vitiligo()
por: Dellatorre, Gerson, et al.
Publicado: (2023) -
Update on the pathogenesis of vitiligo()
por: Marchioro, Helena Zenedin, et al.
Publicado: (2022) -
Optimizing suction blister epidermal graft technique in the surgical
treatment of vitiligo
por: Dellatorre, Gerson, et al.
Publicado: (2017) -
Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation()()
por: Komnitski, Melpone, et al.
Publicado: (2020)